R&G PharmaStudies Co., Ltd. (SZSE: 301333)
Health Care · Life Sciences Tools & Services · CN
CN¥58.75
-5.80% today · +5.7% 1Y
R&G PharmaStudies Co., Ltd. (SZSE: 301333) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $838.91M.
Over the last twelve months the share price has gained 5.7%, trading between 43.79 and 91.78.
Tweenvest scores R&G PharmaStudies Co., Ltd. across four factors: quality 71/100, value 30/100, growth 49/100, dividend 6/100. Its strongest factor is quality.
301333 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $838.91M
- Revenue (TTM)
- $129.94M
- P/E
- 41.92
- EPS
- 1.40
- Dividend yield
- 0.27%
- Beta (5Y)
- 0.39
- 52-week high
- CN¥91.78
- 52-week low
- CN¥43.79
- Avg volume (3M)
- —
- Shares outstanding
- 95.99M
- Employees
- —
- Next earnings
- —
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $232.67B | $632.56 | +0.52% |
| Danaher CorporationNYSE: DHR | $153.85B | $218.85 | +1.36% |
| WuXi AppTec Co., Ltd.SHSE: 603259 | $72.12B | CN¥162.86 | -3.00% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $51.75B | ₩1,551,000.00 | +0.19% |
| Lonza Group AGSWX: LONN | $51.61B | CHF590.20 | -0.34% |
| Agilent Technologies, Inc.NYSE: A | $44.91B | $160.25 | +0.79% |
| IQVIA Holdings Inc.NYSE: IQV | $42.77B | $259.82 | +1.47% |
| Waters CorporationNYSE: WAT | $40.35B | $410.70 | +1.49% |
Figures last refreshed Aug 18, 2026.